michigan glp-1 side effect legal team Although 40 percent of people stop taking GLP-1s for obesity within a year, many resume treatment within two years of cessation, according to research presented at #ENDO2026 semaglutide gastroparesis lawyer in michigan

Summary: Current evidence from regulatory reviews and clinical trials does not establish a causal link between GLP-1 agonists and suicidal ideation, though ongoing monitoring continues

How do we use this product

Good tolerability: Side effects were generally mild and included injection site reactions, headache, and diarrhea

The medications are also associated with nausea and vomiting, which can interfere with nutrient absorption, says Bonnie Newlin, RD, a nutritionist in Denver, who frequently counsels patients who are taking GLP-1 weight loss medications

Gaudana R, Ananthula HK, Parenky A, Mitra AK

Supports brain function